JOHN CAMPBELL: Open Payments
NPI 1417901232 · KENTWOOD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,020 in 47 payments from 17 companies in 2025. Trend: 2023 $939 · 2024 $992 · 2025 $1,020
Food & beverage: $1,020
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $166 |
| GlaxoSmithKline, LLC. | 8 | $136 |
| AstraZeneca Pharmaceuticals LP | 5 | $94 |
| ABBVIE INC. | 4 | $77 |
| Indivior Inc. | 4 | $66 |
| PFIZER INC. | 2 | $62 |
| Supernus Pharmaceuticals, Inc. | 2 | $61 |
| Exact Sciences Corporation | 4 | $60 |
| Lilly USA, LLC | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
Products named: Wegovy, TRELEGY ELLIPTA, FARXIGA, SUBLOCADE, Qelbree, Cologuard Collection Kit, REXULTI, COBENFY.
Industry payments across MI — which companies pay providers there.
